PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Embolic protection devices: An overview PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global occlusion devices market • Global distal filter devices market PART 07: Market segmentation by treatment procedure • Global embolic protection devices market for coronary artery treatment • Global embolic protection devices for carotid artery treatment • Global embolic protection devices for peripheral artery treatment PART 08: Market segmentation by end-users • ASCs • Hospitals • Physicians' offices PART 09: Geographical segmentation • Embolic protection devices market in Americas • Embolic protection devices market in EMEA • Embolic protection devices market in APAC PART 10: Market drivers • Incidence of cardiac diseases and adoption of PCI • Outsourcing PCI device research to CROs • Venture capitals for market entry of start-ups • Minimally invasive procedures with improved medical imaging PART 11: Impact of drivers PART 12: Market challenges • High cost of stenting • Product recalls • Lack of product differentiation leading to marginal profits PART 13: Impact of drivers and challenges PART 14: Market trends • Integrated technologies by small companies for market penetration • Emergence of digital cath-labs in hospitals • Transforming marketing and sales strategies for embolic protection devices PART 15: Vendor landscape • Competitive scenario PART 16: Major vendors • Abbott Laboratories • Boston Scientific • Cardinal Health • Medtronic • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Embolic protection devices: Clinical studies with positive results Exhibit 03: Global embolic protection devices market: New entrants Exhibit 04: Scope of embolic protection devices in various regions 2016-2020 Exhibit 05: Global embolic protection devices market: Impact assessment Exhibit 06: Global embolic protection devices market 2015-2020 ($ millions) Exhibit 07: Global embolic protection devices market: Metrics analysis Exhibit 08: Five forces analysis Exhibit 09: Global embolic protection devices market segmentation by product 2015 Exhibit 10: Global balloon occlusion devices market: Metrics analysis Exhibit 11: Global distal filter devices market: Metrics analysis Exhibit 12: Global embolic protection devices market segmentation by treatment procedure 2015 Exhibit 13: Global embolic protection devices market for coronary artery treatment: Market overview Exhibit 14: Global embolic protection devices for carotid artery treatment: Market overview Exhibit 15: Global embolic protection devices for peripheral artery treatment: Market overview Exhibit 16: Global embolic protection devices market segmentation by end-user 2015 Exhibit 17: Comparison of reimbursement for ASCs, hospital outpatient departments, and physicians' offices in US Exhibit 18: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe Exhibit 19: Global embolic protection devices market segmentation by geography 2015 Exhibit 20: Global embolic protection devices market segmentation by geography 2020 Exhibit 21: Global embolic protection devices market segmentation by geography 2015-2020 Exhibit 22: Global embolic protection devices market segmentation by geography 2015-2020 ($ millions) Exhibit 23: Number of coronary angiography procedures in few countries in Americas 2013 Exhibit 24: Embolic protection devices market in Americas 2015-2020 ($ millions) Exhibit 25: Embolic protection devices market in the Americas: Metrics analysis for various countries Exhibit 26: Implements amended in ACA in US Exhibit 27: Impact of ACO and ACA on embolic protection devices Exhibit 28: Embolic protection devices in EMEA: Market overview Exhibit 29: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013 Exhibit 30: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013 Exhibit 31: Embolic protection devices market in EMEA 2015-2020 ($ millions) Exhibit 32: Embolic protection devices market in APAC: Market overview Exhibit 33: Embolic protection devices market in APAC 2015-2020 ($ millions) Exhibit 34: CROs that helped companies receive regulatory approvals for PCI devices Exhibit 35: New market entrants Exhibit 36: Impact of drivers Exhibit 37: Product recalls: Embolic protection devices and stents Exhibit 38: Impact of drivers and challenges Exhibit 39: Some advanced embolic protection devices Exhibit 40: Marketing and sales strategies of large and small companies Exhibit 41: Global embolic protection devices market: Competitive landscape analysis 2015 Exhibit 42: Global market penetration of various companies 2015 Exhibit 43: Abbott Laboratories: Metrics analysis Exhibit 44: Boston Scientific: Metrics analysis Exhibit 45: Cardinal Health: Metrics analysis Exhibit 46: Medtronic: Metrics analysis Exhibit 47: Other prominent vendors

Abbott Laboratories, Boston Scientific, Cardinal Health, Medtronic, Abiomed, Advansource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, AngioSlide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Innovative Cardiovascular Solutions, Keystone Heart, Transverse Medical.